PDB49 Resource Use in Patients With Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy: 6-Month Data From Choice

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb24 - Baseline Characteristics of German Diabetes Mellitus Type-2 Patients Who Initiated Insulin Usage: A Claims Data Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Diabetes Management and Healthcare Resource Use When Intensifying From Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

A Retrospective Database Analysis of Insulin Use Patterns in Insulin-Naïve Patients With Type 2 Diabetes Initiating Basal Insulin or Mixtures

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2010English

Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects With Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Health Care Resource Use and Costs in Patients With Type 2 Diabetes Mellitus After Treatment Initiation With Saxagliptin or Sitagliptin

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy

Canadian Journal of Diabetes
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2014English

Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy